Atlas Trials

OX2 Therapeutics

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch OX2 Therapeutics

RecordFirmDate
CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults (NCT06305910)OX2 Therapeutics2024-03-15
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma (NCT04642937)OX2 Therapeutics2020-12-01

Track OX2 Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.